To determine whether tumor-intrinsic cGAS activity was required for Prmt9 KD-mediated immunity, MA9-OVA cells with cGAS KO (Extended Data Fig. 8n) were transduced with either inducible shPrmt9 or shCtrl and implanted into WT recipients. Here, PRMT9 is linked to neoplasm.